OnCap™ HC and HC Plus Additives are specially formulated to meet material performance requirements in today’s healthcare environments. In addition to advancing product performance, some OnCap HC Additives are formulated to improve manufacturing efficiency of medical parts and devices. OnCap HC and HC Plus Additives can be used in a wide range of polymer resins.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; including recessionary conditions • The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows • Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • An inability to raise or sustain prices for products or services; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; • The ability to obtain required regulatory approvals and otherwise consummate the proposed sales of the Distribution business; and • Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions Use of Non-GAAP Measures This presentation includes the use of both GAAP (generally accepted accounting principles) and non-GAAP financial measures. Additionally, Adjusted EPS excludes the impact of special items and amortization expense associated with intangible assets. 2 PRO FORMA 2021 TO 2022 BRIDGE 3 2021 EPS from Continuing Operations 1.69$ Pro Forma & Special Items 1.33 Proforma 2021 Adjusted EPS 3.02$ FX Impact (0.22) China Lockdowns / Russia Import Sales (0.24) Outdoor High Performance (0.13) Dyneema 0.06 Color, Additives and Inks 0.38 Legacy Specialty Engineered Materials 0.22 Other 0.01 Proforma 2022 Adjusted EPS 3.10$ COLOR, ADDITIVES AND INKS 7% (4%) (9%) 6% (10%) 0% 1% 2% 7% 10% 4% (3%) 12% (6%) 5% 6% 9% 610 650 624 649 587 565 581 526 2,402 2,390 589 650 589 649 543 565 545 526 2,266 2,390 116 121 112 119 93 95 88 79 409 414 113 121 106 119 87 95 84 79 390 414 10% 4 (1%) PRO FORMA SPECIALTY ENGINEERED MATERIALS 16%8% (8%) (8%) 3% (6%) (6%) (2%) 2% 20%12% (1%) (2%) 5% (1%) (2%) 3% 6% 314 338 348 343 325 300 321 295 1,308 1,276 303 338 329 343 303 300 301 295 1,236 1,276 67 78 75 77 70 66 66 62 278 283 65 78 73 77 67 66 63 62 268 283 5 Constant Currency Adjusted EPS Adjusted EPS PRO FORMA AVIENT 10% (3%) (21%) 3% 9% 5% 7% (5%) (9%) (1%) (1%) (12%) 1% 17% 8% (14%) 11% 14% 10% 11% 2% (3%) 5% 8% (5%) 7% 925 987 973 992 912 867 902 823 3,712 3,669 893 987 919 992 847 867 845 823 3,504 3,669 161 176 164 172 142 141 133 117 600 606 155 176 157 172 131 141 123 117 566 6068% 2% 0.84 0.98 0.87 0.96 0.70 0.68 0.61 0.48 3.02 3.10 0.79 0.98 0.82 0.96 0.63 0.68 0.56 0.48 2.80 3.10 17% 24% 6 March 31, 2022 March 31, 2021 Net income from continuing operations $ 64.7 $ 60.4 Net income attributable to noncontrolling interests (0.3) (0.4) Net income from continuing operations attributable to Avient shareholders $ 64.4 $ 0.70 $ 60.0 $ 0.65 Special items, after tax $ 6.4 $ 0.07 $ 2.6 $ 0.03 APM pro forma adjustments 2.6 0.03 (3.1) (0.03) Amortization expense, after tax 17.4 0.19 17.9 0.19 Adjusted pro forma net income / EPS $ 90.8 $ 0.98 $ 77.4 $ 0.84 Weighted average diluted shares 92.3 92.2 June 30, 2022 June 30, 2021 Net income from continuing operations $ 62.8 $ 50.2 Net income attributable to noncontrolling interests — (0.6) Net income from continuing operations attributable to Avient shareholders $ 62.8 $ 0.68 $ 49.6 $ 0.54 Special items, after tax $ 3.2 $ 0.03 $ 11.7 $ 0.13 APM pro forma adjustments 5.2 0.06 1.4 0.02 Amortization expense, after tax 17.2 0.19 17.8 0.19 Adjusted pro forma net income / EPS $ 88.4 $ 0.96 $ 80.5 $ 0.87 Weighted average diluted shares 92.1 92.4 September 30, 2021 Reconciliation to Condensed Consolidated Statements of Income Avient EPS Net income from continuing operations $ 33.4 Net income attributable to noncontrolling interests 0.3 Net income from continuing operations attributable to Avient shareholders $ 33.7 $ 0.37 Special items, after tax $ 11.7 $ 0.13 APM pro forma adjustments 1.5 0.02 Amortization expense, after tax 17.6 0.19 Adjusted pro forma net income / EPS $ 64.5 $ 0.70 Weighted average diluted shares 92.2 Adjusted EPS may not recalculate due to rounding. 1 December 31, 2021 Year Ended December 31, 2021 Net income from continuing operations $ 11.2 $ 155.2 Net income attributable to noncontrolling interests 0.9 0.2 Net income from continuing operations attributable to Avient shareholders $ 12.1 $ 0.13 $ 155.4 $ 1.69 Special items, after tax $ 24.0 $ 0.26 $ 50.0 $ 0.54 APM pro forma adjustments 2.5 0.03 1.6 0.02 Amortization expense, after tax 17.8 0.19 71.1 0.77 Adjusted pro forma net income / EPS $ 56.4 $ 0.61 $ 278.1 $ 3.02 Weighted average diluted shares 92.4 92.1 Reconciliation of Color, Additives and Inks EBITDA Operating Income 88.8 86.3 66.8 61.2 303.1 94.5 93.6 Depreciation and amortization 27.4 25.3 26.6 26.4 105.7 26.0 25.9 EBITDA $ 116.2 $ 111.6 $ 93.4 $ 87.6 $ 408.8 $ 120.5 $ 119.5 Q1 2021 Q2 2021 Q3 2021 Pro forma Pro forma Pro forma Pro forma Pro forma Pro forma Operating Income 32.6 9.1 41.7 35.8 13.9 49.7 30.0 15.2 45.2 Depreciation and amortization 7.8 17.5 25.3 8.1 17.3 25.4 7.9 17.1 25.0 EBITDA $ 40.4 $ 26.6 $ 67.0 $ 43.9 $ 31.2 $ 75.1 $ 37.9 $ 32.3 $ 70.2 Q4 2021 YTD 2021 Pro forma Pro forma Pro forma Pro forma Operating Income 27.1 11.7 38.8 125.5 49.9 175.4 Depreciation and amortization 8.0 18.9 26.9 31.8 70.8 102.6 EBITDA $ 35.1 $ 30.6 $ 65.7 $ 157.3 $ 120.7 $ 278.0 2 Q1 2022 Q2 2022 Pro forma Pro forma Pro forma Pro forma Operating Income 38.3 15.4 53.7 35.2 17.7 52.9 Depreciation and amortization 7.8 16.6 24.4 7.7 16.6 24.3 EBITDA $ 46.1 $ 32.0 $ 78.1 $ 42.9 $ 34.3 $ 77.2 Q1 2021 Q2 2021 Q3 2021 Pro forma Pro forma Pro forma Pro forma Pro forma Pro forma Net income from continuing operations 60.4 (3.1) 57.3 50.2 1.4 51.6 33.4 1.5 34.9 Income tax expense 16.3 1.1 17.4 13.8 1.3 15.1 2.0 2.5 4.5 Interest expense 19.3 11.1 30.4 19.5 11.2 30.7 19.0 11.2 30.2 Depreciation and amortization 36.9 17.5 54.4 33.6 17.3 50.9 36.6 17.1 53.7 EBITDA 132.9 26.6 159.5 117.1 31.2 148.3 91.0 32.3 123.3 Special items, before tax 2.4 — 2.4 14.2 — 14.2 19.9 — 19.9 Depreciation included in special items (0.6) — (0.6) 1.4 — 1.4 (0.9) — (0.9) Adjusted EBITDA $ 134.7 $ 26.6 $ 161.3 $ 132.7 $ 31.2 $ 163.9 $ 110.0 $ 32.3 $ 142.3 Q4 2021 YTD 2021 Pro forma Pro forma Pro forma Pro forma Net income from continuing operations 11.2 2.5 13.7 155.2 1.6 156.8 Income tax expense 16.2 (1.9) 14.3 48.3 3.7 52.0 Interest expense 17.5 11.1 28.6 75.3 44.6 119.9 Depreciation and amortization 37.9 18.9 56.8 145.0 70.8 215.8 EBITDA 82.8 30.6 113.4 423.8 120.7 544.5 Special items, before tax 20.6 — 20.6 57.1 — 57.1 Depreciation included in special items (1.6) — (1.6) (1.7) — (1.7) Adjusted EBITDA $ 101.8 $ 30.6 $ 132.4 $ 479.2 $ 120.7 $ 599.9 3 Q1 2022 Q2 2022 Pro forma Pro forma Pro forma Pro forma Net income from continuing operations 64.7 2.6 67.3 62.8 5.2 68.0 Income tax expense 20.0 1.7 21.7 22.7 1.4 24.1 Interest expense 16.9 11.1 28.0 16.2 11.1 27.3 Depreciation and amortization 37.6 16.6 54.2 36.3 16.6 52.9 EBITDA 139.2 32.0 171.2 138.0 34.3 172.3 Special items, before tax 6.6 — 6.6 0.9 — 0.9 Depreciation included in special items (2.1) — (2.1) (1.1) — (1.1) Adjusted EBITDA $ 143.7 $ 32.0 $ 175.7 $ 137.8 $ 34.3 $ 172.1 Reconciliation of Specialty Engineered Pro Forma Sales Sales 214.7 238.9 231.7 226.3 911.6 243.1 242.3 Pro forma APM 98.9 108.8 93.8 94.9 396.4 94.8 100.5 Pro forma sales $ 313.6 $ 347.7 $ 325.5 $ 321.2 $ 1,308.0 $ 337.9 $ 342.8 Reconciliation of Avient Pro Forma Sales Sales 826.0 864.5 818.0 807.1 3,315.6 892.2 891.0 Pro forma APM 98.9 108.8 93.8 94.9 396.4 94.8 100.5 Pro forma sales $ 924.9 $ 973.3 $ 911.8 $ 902.0 $ 3,712.0 $ 987.0 $ 991.5 4 IR Slides V17 - 9.26 324pm IR Deck - AVNT-2022.09.27 Pre Release v2

Relying on material knowledge and state-of-the- art equipment, key elements such as polymer properties, surface finish, and regulatory compliance are carefully considered in the masterbatch formulation to fulfill both the application and the customers’ specific requirements. These include high-temperature, engineering and recycled polymers. For our masterbatches and ready-to-use formulations going into electrical and electronic applications, we can develop formulations to comply with and provide the following declarations as needed on a product- specific basis: • Food contact according to Reg.

This new color and special effects option helps polymer packaging do just that. Available in both liquid and solid formulations, Impress helps to create packaging with a brilliant glossy, metallic surface in unlimited color options. PRODUCT BULLETIN APPLICATIONS • Beverages • Personal Care • Consumer Goods Compatible with: • PET • Injection blow molding TECHNOLOGY COMPONENTS Impress is formulated using an additive that adds a brilliant ultra-glossy appearance to packaging made with semi-crystalline polymers.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows including without any limitation, any supply chain and logistics issues; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; our ability to consummate and successfully integrate acquisitions; and amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions. Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Sales: Color, Additives and Inks $ 624.4 $ 226.8 $ 1,233.7 $ 483.3 Specialty Engineered Materials 240.6 158.8 457.1 344.1 Distribution 404.4 238.8 767.1 528.3 Corporate and eliminations (34.2) (15.3) (60.4) (35.1) Sales $ 1,235.2 $ 609.1 $ 2,397.5 $ 1,320.6 Gross margin: Color, Additives and Inks $ 193.4 $ 75.7 $ 390.9 $ 165.1 Specialty Engineered Materials 69.6 42.5 134.3 95.1 Distribution 40.1 27.2 79.4 60.8 Corporate and eliminations (14.4) 4.3 (13.5) 0.2 Gross margin $ 288.7 $ 149.7 $ 591.1 $ 321.2 Selling and administrative expense: Color, Additives and Inks $ 107.1 $ 43.4 $ 215.8 $ 92.3 Specialty Engineered Materials 32.3 25.5 62.8 55.8 Distribution 16.4 12.6 31.7 26.8 Corporate and eliminations 24.8 30.2 52.3 55.5 Selling and administrative expense $ 180.6 $ 111.7 $ 362.6 $ 230.4 Operating income: Color, Additives and Inks $ 86.3 $ 32.3 $ 175.1 $ 72.8 Specialty Engineered Materials 37.3 17.0 71.5 39.3 Distribution 23.7 14.6 47.7 34.0 Corporate and eliminations (39.2) (25.9) (65.8) (55.3) Operating income $ 108.1 $ 38.0 $ 228.5 $ 90.8 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 111.6 $ 42.9 $ 227.7 $ 94.4 Specialty Engineered Materials 45.4 24.6 87.4 54.4 Distribution 23.9 14.7 48.1 34.2 Corporate and eliminations (39.0) (23.3) (63.8) (51.4) Other income, net 1.2 9.5 $ 2.7 $ 11.1 EBITDA $ 143.1 $ 68.4 $ 302.1 $ 142.7 12 Attachment 7 Avient Corporation Reconciliation of Non-GAAP Financial Measures (Unaudited) (In millions, except per share data) Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance. Reconciliation of Pro Forma Adjusted Earnings per Share: Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Year Ended December 31, 2020 Net income from continuing operations attributable to Avient shareholders $ 23.0 $ 56.1 $ 132.0 Special items, after tax 2.6 11.2 24.8 Adjusted net income from continuing operations excluding special items 25.6 67.3 156.8 Clariant MB pro forma adjustments to net income from continuing operations(2) 12.9 20.7 20.7 Pro forma adjusted net income from continuing operations attributable to Avient shareholders $ 38.5 $ 88.0 $ 177.5 Weighted average diluted shares 91.8 89.4 90.6 Pro forma impact to diluted shares from January 2020 equity offering(2) — 2.9 1.5 Pro forma weighted average diluted shares 91.8 92.3 92.1 Adjusted EPS - excluding special items pro forma for Clariant MB acquisition $ 0.42 $ 0.95 $ 1.93 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 14 Three Months Ended June 30, 2020 Reconciliation of Pro Forma Adjusted Earnings per Share Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(2) Pro Forma Adjusted Avient Sales $ 609.1 $ — $ 609.1 $ 261.1 $ 870.2 Operating income $ 38.0 $ 9.0 $ 47.0 $ 22.0 $ 69.0 Interest expense, net (16.2) — (16.2) (5.3) (21.5) Other income, net 9.5 (6.6) 2.9 — 2.9 Income taxes (7.9) 0.2 (7.7) (3.8) (11.5) Net income attributable to noncontrolling interests (0.4) — (0.4) — (0.4) Net income from continuing operations attributable to Avient shareholders $ 23.0 $ 2.6 $ 25.6 $ 12.9 $ 38.5 Weighted average diluted shares 91.8 Pro forma adjusted EPS $ 0.42 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition Six Months Ended June 30, 2020 Reconciliation of Pro Forma Adjusted Earnings per Share: Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(2) Pro Forma Adjusted Avient Sales $ 1,320.6 $ — $ 1,320.6 $ 540.5 $ 1,861.1 Operating income $ 90.8 $ 18.7 $ 109.5 $ 45.0 $ 154.5 Interest expense, net (25.6) — (25.6) (18.1) (43.7) Other income, net 11.1 (6.7) 4.4 — 4.4 Income taxes (19.8) (0.8) (20.6) (6.2) (26.8) Net income attributable to noncontrolling interests (0.4) — (0.4) — (0.4) Net income from continuing operations attributable to Avient shareholders $ 56.1 $ 11.2 $ 67.3 $ 20.7 $ 88.0 Weighted average diluted shares 89.4 Impact to diluted shares from January 2020 equity offering 2.9 Pro forma weighted average diluted shares 92.3 Pro forma adjusted EPS $ 0.95 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 15 Reconciliation of EBITDA by Segment Three Months Ended June 30, Six Months Ended June 30 2021 2020 2021 2020 Operating income: Color, Additives and Inks $ 86.3 $ 32.3 $ 175.1 $ 72.8 Specialty Engineered Materials 37.3 17.0 71.5 39.3 Distribution 23.7 14.6 47.7 34.0 Corporate and eliminations (39.2) (25.9) (65.8) (55.3) Operating income $ 108.1 $ 38.0 $ 228.5 $ 90.8 Items below OI in Corporate: Other income, net $ 1.2 $ 9.5 $ 2.7 $ 11.1 Depreciation & amortization: Color, Additives and Inks $ 25.3 $ 10.6 $ 52.6 $ 21.6 Specialty Engineered Materials 8.1 7.6 15.9 15.1 Distribution 0.2 0.1 0.4 0.2 Corporate and eliminations 0.2 2.6 2.0 3.9 Depreciation & Amortization $ 33.8 $ 20.9 $ 70.9 $ 40.8 EBITDA: Color, Additives and Inks $ 111.6 $ 42.9 $ 227.7 $ 94.4 Specialty Engineered Materials 45.4 24.6 87.4 54.4 Distribution 23.9 14.7 48.1 34.2 Corporate and eliminations (39.0) (23.3) (63.8) (51.4) EBITDA $ 143.1 $ 68.4 $ 302.1 $ 142.7 EBITDA as a % of Sales: Color, Additives and Inks 17.9 % 18.9 % 18.5 % 19.5 % Specialty Engineered Materials 18.9 % 15.5 % 19.1 % 15.8 % Distribution 5.9 % 6.2 % 6.3 % 6.5 % 16 Reconciliation of Pro Forma EBITDA - Color, Additives and Inks Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Sales: Color, Additives and Inks $ 624.4 $ 226.8 $ 1,233.7 $ 483.3 Clariant MB pro forma adjustments(2) — 261.1 — 540.5 Pro forma sales $ 624.4 $ 487.9 $ 1,233.7 $ 1,023.8 Operating income: Color, Additives and Inks $ 86.3 $ 32.3 $ 175.1 $ 72.8 Clariant MB pro forma adjustments(2) — 22.0 — 45.0 Pro forma operating income $ 86.3 $ 54.3 $ 175.1 $ 117.8 Depreciation & amortization: Color, Additives and Inks $ 25.3 $ 10.6 $ 52.6 $ 21.6 Clariant MB pro forma adjustments(2) — 15.0 — 30.1 Pro forma depreciation & amortization $ 25.3 $ 25.6 $ 52.6 $ 51.7 Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA): Color, Additives and Inks $ 111.6 $ 42.9 $ 227.7 $ 94.4 Clariant MB pro forma adjustments(2) — 37.0 — 75.1 Pro forma EBITDA $ 111.6 $ 79.9 $ 227.7 $ 169.5 Pro forma EBITDA as a % of Sales 17.9 % 16.4 % 18.5 % 16.6 % (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition Three Months Ended June 30, Six Months Ended June 30, Reconciliation to Pro Forma Adjusted EBITDA: 2021 2020 2021 2020 Net income from continuing operations – GAAP $ 69.4 $ 23.4 $ 149.1 $ 56.5 Income tax expense 20.4 7.9 43.3 19.8 Interest expense 19.5 16.2 38.8 25.6 Depreciation and amortization from continuing operations 33.8 20.9 70.9 40.8 EBITDA $ 143.1 $ 68.4 $ 302.1 $ 142.7 Special items, before tax 14.2 2.4 16.6 12.0 Interest expense included in special items — (0.5) — (0.5) Depreciation and amortization included in special items 1.4 (1.2) 0.8 (1.2) Adjusted EBITDA $ 158.7 $ 69.1 $ 319.5 $ 153.0 Clariant MB pro forma adjustments(2) — 37.0 — 75.1 Pro forma adjusted EBITDA $ 158.7 $ 106.1 $ 319.5 $ 228.1

LAWN & GARDEN OEM F A N F O R B L O W E R / V A C U U M • Lighter than incumbent magnesium part to improve start- up efficiency and enhance overall user experience • High impact resistance to withstand the effect of fast- moving landscaping debris • Good dimensional stability to meet tight tolerances of assembly • Expertise to guide next-generation product development • Proved material performance success through extensive Mold Flow and FEA simulations to prove concept without prototyping and minimize development costs • Produced material globally to support regional demands • Referred customer to US-based dependable mold shops to support local production Complēt™ MT 40% Long Glass Fiber Impact Modified Formulation KEY REQUIREMENTS WHY AVIENT? All Rights Reserved https://www.avient.com/products/engineered-polymer-formulations/high-temperature-polymer-formulations/complet-long-fiber-reinforced-structural-thermoplastics

LAWN & GARDEN OEM F A N F O R B L O W E R / V A C U U M • Lighter than incumbent magnesium part to improve start- up efficiency and enhance overall user experience • High impact resistance to withstand the effect of fast- moving landscaping debris • Good dimensional stability to meet tight tolerances of assembly • Expertise to guide next-generation product development • Proved material performance success through extensive Mold Flow and FEA simulations to prove concept without prototyping and minimize development costs • Produced material globally to support regional demands • Referred customer to US-based dependable mold shops to support local production Complēt™ MT 40% Long Glass Fiber Impact Modified Formulation KEY REQUIREMENTS WHY AVIENT? All Rights Reserved https://www.avient.com/products/engineered-polymer-formulations/high-temperature-polymer-formulations/complet-long-fiber-reinforced-structural-thermoplastics

As one of the world’s leading specialty polymer materials, services and solution companies, Avient contributes to value creation with innovative and sustainable solutions for customers from many industries. Polymers 48 Purchased polymers data, broken out by polymer type, was obtained in weight. As one of the world’s leading specialty polymer materials, services and solution companies, Avient contributes to value creation with innovative and sustainable solutions for customers from many industries.

Specialty running products manufacturer adapts shoes to the runner and the run

CLEVELAND – NOVEMBER 14, 2023 – Dyneema®, owned by Avient Corporation, a leading provider of specialty and sustainable material solutions, today announced its Circular Solution for Dyneema® fiber end-of-life recycling has been selected as a finalist for the prestigious Milipol Innovation Awards in the corporate social responsibility (CSR) category.